Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Shares Outstanding: 84.94M for Nov. 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 08, 2024 | 84.94M |
September 30, 2024 | 84.92M |
September 12, 2024 | 84.44M |
July 26, 2024 | 70.37M |
June 30, 2024 | 70.34M |
May 03, 2024 | 64.68M |
April 18, 2024 | 64.67M |
March 31, 2024 | 64.65M |
March 08, 2024 | 64.65M |
December 31, 2023 | 64.58M |
November 03, 2023 | 61.79M |
September 30, 2023 | 61.79M |
August 04, 2023 | 61.07M |
June 30, 2023 | 61.06M |
May 05, 2023 | 56.68M |
April 18, 2023 | 56.68M |
March 31, 2023 | 56.67M |
March 03, 2023 | 56.67M |
December 31, 2022 | 53.72M |
December 23, 2022 | 49.52M |
November 04, 2022 | 37.61M |
September 30, 2022 | 37.61M |
Date | Value |
---|---|
August 16, 2022 | 37.61M |
August 05, 2022 | 25.36M |
June 30, 2022 | 25.36M |
May 06, 2022 | 25.28M |
April 22, 2022 | 25.27M |
March 31, 2022 | 25.27M |
February 20, 2022 | 25.27M |
December 31, 2021 | 25.27M |
November 05, 2021 | 25.27M |
September 30, 2021 | 25.26M |
August 06, 2021 | 25.13M |
June 30, 2021 | 25.13M |
May 07, 2021 | 25.11M |
March 31, 2021 | 25.04M |
March 26, 2021 | 25.13M |
March 19, 2021 | 25.13M |
February 22, 2021 | 25.10M |
February 12, 2021 | 25.10M |
February 09, 2021 | 23.97M |
February 05, 2021 | 23.97M |
February 01, 2021 | 22.72M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
22.72M
Minimum
Feb 01 2021
84.94M
Maximum
Nov 08 2024
44.32M
Average
37.61M
Median
Aug 16 2022
Shares Outstanding Benchmarks
Eli Lilly and Co | 949.32M |
Viking Therapeutics Inc | 111.44M |
Biomarin Pharmaceutical Inc | 190.58M |
Elite Pharmaceuticals Inc | 1.068B |
Verrica Pharmaceuticals Inc | 45.60M |